Guardian Pharmacy Services (GRDN) Cash & Equivalents (2023 - 2026)

Guardian Pharmacy Services has disclosed Cash & Equivalents across 4 years of filings, most recently posting $64.9 million for Q1 2026.

• Cash & Equivalents for Q1 2026 came in at $64.9 million, up 363.55% year-over-year; the trailing twelve-month figure through Mar 2026 was $64.9 million (up 363.55% YoY), and the FY2025 annual result was $65.6 million, up 1308.13% from the prior year.
• Cash & Equivalents came in at $64.9 million for Q1 2026 at Guardian Pharmacy Services, down from $65.6 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $65.6 million in Q4 2025 to a low of $752000.0 in Q4 2023.
• The 4-year median for Cash & Equivalents is $27.7 million (2025), against an average of $30.3 million.
• Peak annual rise in Cash & Equivalents reached 1308.13% in 2025, while the deepest fall reached 1.97% in 2025.
• Guardian Pharmacy Services' Cash & Equivalents stood at $752000.0 in 2023, then soared by 519.68% to $4.7 million in 2024, then jumped by 1308.13% to $65.6 million in 2025, then slipped by 1.11% to $64.9 million in 2026.
• The last three Cash & Equivalents figures came in at $64.9 million (Q1 2026), $65.6 million (Q4 2025), and $36.5 million (Q3 2025), per Business Quant data.